Mohit Kumar Jolly
Reproducibility track record
9
assessed papers
87/100
mean reproducibility
8
reproduced (C1–C2)
0
flagged
225
total citations
flag rate:
0%
(0/9)
The share of this author’s assessed papers carrying a ⚑ flag. A concentration is a prompt for expert review — never, on its own, a determination about the person.
Authorship role
first author: 0
last author: 8
Topics
Funders
—
Frequent co-authors
Sarthak Sahoo 4Susmita Mandal 3Jason A. Somarelli 3Manas Sehgal 3Kishore Hari 2Maalavika Pillai 2Soundharya Ramu 2Herbert Levine 2Syamanthak Srikrishnan 1Rohini Janivara 1
Institutions
Indian Institute of Science Bangalore 8Duke University 3Center for Theoretical Biological Physics 2Rice University 2University of Göttingen 1St.John's Medical College Hospital 1
Geography (author institutions)
IN 8US 5AU 2DE 1
Co-author network
Collaborators, sized by shared output and coloured by their own reproducibility (green = high, red = low). Click a node to open their card. A pattern is a prompt for review, never a determination.
How this author’s assessed papers reproduced — the outcome of reproduction attempts, not a judgement of the person. Coverage is partial and grows over time.
Assessed papers (9)
-
Mutually exclusive teams-like patterns of gene regulation characterize phenotypic heterogeneity along the noradrenergic-mesenchymal axis in neuroblastoma.
2024 L1 87/100
-
Proneural-mesenchymal antagonism dominates the patterns of phenotypic heterogeneity in glioblastoma.
2024 L1 100/100
-
Increased prevalence of hybrid epithelial/mesenchymal state and enhanced phenotypic heterogeneity in basal breast cancer.
2024 95/100
-
Emergent dynamics of underlying regulatory network links EMT and androgen receptor-dependent resistance in prostate cancer.
2023 L2 78/100
-
A systems-level analysis of the mutually antagonistic roles of RKIP and BACH1 in dynamics of cancer cell plasticity.
2023 95/100
-
Topological signatures in regulatory network enable phenotypic heterogeneity in small cell lung cancer.
2021 L1 94/100
-
A mechanistic model captures the emergence and implications of non-genetic heterogeneity and reversible drug resistance in ER+ breast cancer cells.
2021 85/100
-
Transcriptomic-Based Quantification of the Epithelial-Hybrid-Mesenchymal Spectrum across Biological Contexts.
2021 L1 100/100
-
Numb prevents a complete epithelial-mesenchymal transition by modulating Notch signalling.
2017 L1 49/100